Fundraising FoxSungwun
1 known investors
Find your way into Sungwun
Sign up to see every warm intro you have to Sungwun
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sungwun team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sungwun Pharmacopia develops active pharmaceutical ingredients (APIs) and biopharmaceutical drugs, including antiviral compounds such as remdesivir and favipiravir, which it manufactures and licenses to pharmaceutical partners. The company also works on microbiome-related technology and has partnered with Indonesian pharmaceutical firm PT. Kimia Farma.
Investors · 1
Frequently asked questions
- What does Sungwun do?
- Sungwun Pharmacopia develops active pharmaceutical ingredients (APIs) and biopharmaceutical drugs, including antiviral compounds such as remdesivir and favipiravir, which it manufactures and licenses to pharmaceutical partners. The company also works on microbiome-related technology and has partnered with Indonesian pharmaceutical firm PT. Kimia Farma.
- Who are Sungwun's investors?
- Sungwun's investors include Aju IB Investment.